搜尋結果
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for ...
Bastillepost· 2 日前ImmunityBio, Inc. ( NASDAQ: IBRX ), an immunotherapy company, today announced that the U.S. ...
Hong Kong should offer more training to embattled carers for elderly: advisory body
South China Morning Post· 5 日前“It’s very important to pay attention to [the elderly’s] emotions as well.” Ramped-up publicity ...
Forget Nest And Fitbit, Google One Is Still Missing One Feature
Forbes· 3 日前The newly enhanced Google One subscription, which now includes Fitbit Premium and Nest Aware, ...